Sparta Biopharma launched BioEnthesisâ„¢, an allograft that possesses both mineralized and demineralized layers intended to support healing and repair within the rotator cuff.
BioEnthesis biphasic cancellous bone allograft has an intact porous collagenous matrix for soft tissue ingrowth, and a highly calcified layer to promote osseointegration. It serves as a scaffold to repair the bone of the enthesis and provides a foundation to facilitate tendon incorporation.
Sparta Biopharma plans to focus on alternatives to knee replacements, biological options for rotator cuff surgery and a natural alternative to delay a hip replacement.
Sparta Biopharma launched BioEnthesisâ„¢, an allograft that possesses both mineralized and demineralized layers intended to support healing and repair within the rotator cuff.
BioEnthesis biphasic cancellous bone allograft has an intact porous collagenous matrix for soft tissue ingrowth, and a highly calcified layer to promote...
Sparta Biopharma launched BioEnthesisâ„¢, an allograft that possesses both mineralized and demineralized layers intended to support healing and repair within the rotator cuff.
BioEnthesis biphasic cancellous bone allograft has an intact porous collagenous matrix for soft tissue ingrowth, and a highly calcified layer to promote osseointegration. It serves as a scaffold to repair the bone of the enthesis and provides a foundation to facilitate tendon incorporation.
Sparta Biopharma plans to focus on alternatives to knee replacements, biological options for rotator cuff surgery and a natural alternative to delay a hip replacement.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
